Mind Body Syndrome (MBS) Therapy for the Treatment of Chronic Pain

Chronic Pain Clinical Trial

Official title:

Mind Body Syndrome (MBS) Therapy for the Treatment of Chronic Pain

Clinical Trial Details — Status: Active, not recruiting

Administrative data

• NCT number: NCT02117921
• Other study ID #: 2013P000315
• Status: Active, not recruiting
• Phase: N/A
• Start date: February 2014
• Est. completion date: December 2020

Study information

• Verified date: July 2020
• Source: Beth Israel Deaconess Medical Center
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

To determine if Mind Body Syndrome (MBS) therapy will reduce or eliminate pain in patients suffering from chronic pain syndromes without organic etiology.

Recruitment information / eligibility

• Status: Active, not recruiting
• Enrollment: 20
• Est. completion date: December 2020
• Est. primary completion date: December 2020
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Adult patient 18 > years old

• Chronic pain without clear organic etiology after full evaluation by primary care physician or subspecialist

• Pain persistent for a minimum of 3 days a week for the past three months prior to enrollment

Exclusion Criteria:

• Patients < 18 years of age

• Diagnosed organic disease as cause of pain, such as but not limited to malignancy, neurologic disorder (i.e., amyotrophic lateral sclerosis)

• Patients with a diagnosis of significant psychiatric co-morbidities such as schizophrenia and bi-polar disorder. Mild to moderate depression and anxiety will not be considered as exclusions

• Pregnancy

• Severe depression or recent suicide attempt

Related Conditions & MeSH terms

• Chronic Pain

Intervention

Behavioral:
• One-on-one interview and educational sessions. Reading material for educational series provided.
A one-on-one interview with the patient and the principal investigator and group educational sessions.

Locations

Country	Name	City	State
United States	Beth Israel Deaconess Medical Center	Boston	Massachusetts

Sponsors (1)

Lead Sponsor	Collaborator
Beth Israel Deaconess Medical Center

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Brief Pain Inventory Questionnaire	To determine if Mind Body Syndrome (MBS) therapy will reduce or eliminate pain in patients suffering from chronic pain syndromes without organic etiology.	4 weeks
Primary	SF-12 Health Survey Scoring Demonstration		4 weeks
Secondary	SF-12 Health Survey Scoring Demonstration and Brief Pain Inventory Score		2 weeks, 4 weeks, 6 months